chr3-189207566-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198485.4(TPRG1):āc.182A>Cā(p.Tyr61Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,614,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_198485.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPRG1 | NM_198485.4 | c.182A>C | p.Tyr61Ser | missense_variant | 2/6 | ENST00000345063.8 | NP_940887.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPRG1 | ENST00000345063.8 | c.182A>C | p.Tyr61Ser | missense_variant | 2/6 | 1 | NM_198485.4 | ENSP00000341031.3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251236Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135770
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461744Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727184
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.182A>C (p.Y61S) alteration is located in exon 2 (coding exon 1) of the TPRG1 gene. This alteration results from a A to C substitution at nucleotide position 182, causing the tyrosine (Y) at amino acid position 61 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at